Shoei
Shoei Abe, Wako-Shi JP
Patent application number | Description | Published |
---|---|---|
20080246363 | CONTROLLER OF ELECTRIC MOTOR - A controller able to efficiently operate an electric motor of an axial air-gap type as an electric motor and an electricity generator is provided. | 10-09-2008 |
20080246429 | CONTROLLER OF ELECTRIC MOTOR - A controller of an electric motor for improving operation efficiency in performing electric conducting control of the electric motor of an axial air-gap type is provided. | 10-09-2008 |
Shoei Furukawa, Gifu JP
Patent application number | Description | Published |
---|---|---|
20100204498 | AGENT HAVING NEUROTROPHIC FACTOR-LIKE ACTIVITY - The present invention provides a pharmaceutical agent having high safety and a neurotrophic factor-like activity, which contains, as an active ingredient, any one compound included in fatty acids each having 8 carbon atoms (C8) or having 10 carbon atoms (C10) to 12 carbon atoms (C12) or fatty acid esters thereof, such as 3,7-dimethyloctanoic acid ethyl ester, geranic acid ethyl ester, and the like, each of which has 8 carbon atoms (C8), decanoic acid methyl ester, trans-2-decenoic acid, trans-2-decenoic acid methyl ester, trans-2-decenoic acid ethyl ester, trans-2-decenoic acid-2-decenyl ester, trans-2-decenoic acid cyclohexyl ester, trans-2-decenoic acid isopropyl ester, trans-3-decenoic acid methyl ester, trans-9-decenoic acid methyl ester, and the like, each of which has 10 carbon atoms (C10), trans-10-undecenoic acid methyl ester, trans-10-undecenoic acid ethyl ester, and the like, each of which has 11 carbon atoms (C11), and dodecanoic acid, and the like, each of which has 12 carbon atoms (C12), or salts thereof or prodrugs thereof. | 08-12-2010 |
Shoei Furukawa, Gifu-Shi JP
Patent application number | Description | Published |
---|---|---|
20120264959 | AGENT HAVING NEUROTROPHIC FACTOR-LIKE ACTIVITY - The present invention provides a pharmaceutical agent having high safety and a neurotrophic factor-like activity, which contains, as an active ingredient, any one compound included in fatty acids each having 8 carbon atoms (C8) or having 10 carbon atoms (C10) to 12 carbon atoms (C12) or fatty acid esters thereof, such as 3,7-dimethyloctanoic acid ethyl ester, geranic acid ethyl ester, and the like, each of which has 8 carbon atoms (C8), decanoic acid methyl ester, trans-2-decenoic acid, trans-2-decenoic acid methyl ester, trans-2-decenoic acid ethyl ester, trans-2-decenoic acid-2-decenyl ester, trans-2-decenoic acid cyclohexyl ester, trans-2-decenoic acid isopropyl ester, trans-3-decenoic acid methyl ester, trans-9-decenoic acid methyl ester, and the like, each of which has 10 carbon atoms (C10), trans-10-undecenoic acid methyl ester, trans-10-undecenoic acid ethyl ester, and the like, each of which has 11 carbon atoms (C11), and dodecanoic acid, and the like, each of which has 12 carbon atoms (C12), or salts thereof or prodrugs thereof. | 10-18-2012 |
20130225837 | TRANS-2-DECENOIC ACID DERIVATIVE AND PHARMACEUTICAL AGENT CONTAINING THE SAME - An object of the present invention is to provide a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof and to provide a pharmaceutical agent which contains said compound as an active ingredient and has a highly safe neurotrophic factor-like activity or an alleviating action for side effect induced by administration of anti-cancer agents. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof which is the compound of the present invention is specifically represented by the formula (1): | 08-29-2013 |
20130296425 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR A PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENTS - An object of the present invention is to provide a drug which is effective for prophylaxis or therapy of peripheral nerve disorder occurred as a side effect of the administration of anti-cancer agents. | 11-07-2013 |
20130296426 | ANALGESIC - An object of the present invention is to provide an analgesic effective in a prophylactic or a therapy for various pain diseases. The present invention is to provide an analgesic containing an ester of C | 11-07-2013 |
20150087823 | TRANS-2-DECENOIC ACID DERIVATIVE AND DRUG CONTAINING SAME - The present invention relates to a novel trans-2-decenoic acid derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical agent containing the compound as an active ingredient. The trans-2-decenoic acid derivative or a pharmaceutically acceptable salt, which is the compound of the present invention, is specifically represented by the general formula (I): | 03-26-2015 |
Shoei Kobayashi, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20120170434 | INFORMATION RECORDER, INFORMATION REPRODUCER, RECORDING MEDIA MANUFACTURING SYSTEM, AND INFORMATION RECORDING MEDIA, METHOD AND PROGRAM - The present invention provides an information recording configuration that achieves both difficulty in reading and highly accurate reading. Highly confidential additional information such as encryption key is recorded in a groove signal. During recording of the additional information, a groove signal is recorded that has an amplitude offset setting commensurate with the bit value. During reading of the additional information, a signal R | 07-05-2012 |
Shoei Tsuji, Mie-Gun JP
Patent application number | Description | Published |
---|---|---|
20090291620 | CHEMICAL MECHANICAL POLISHING AQUEOUS DISPERSION, CHEMICAL MECHANICAL POLISHING METHOD, AND CHEMICAL MECHANICAL POLISHING AQUEOUS DISPERSION PREPARATION KIT - A chemical mechanical polishing aqueous dispersion includes: (A) an amino acid, (B) abrasive grains, (C) a surfactant, (D) an oxidizing agent, and (E) ammonia, the ratio (W | 11-26-2009 |